Role of the preoperative circulating tumor DNA KRAS mutation in patients with resectable pancreatic cancer

Li, SN; Zhang, GP; Li, X; Li, XJ; Chen, XB; Xu, Y; Ren, H

Ren, H (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjins Clin Res Ctr Canc, Dept Pancreat Canc,Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China.; Ren, H (corresponding author), Qingdao Univ, Ctr Tumor Immunol & Cytotherapy, Dept Gastroenterol, Affiliated Hosp, Qingdao 266003, Peoples R China.

PHARMACOGENOMICS, 2021; 22 (11): 657

Abstract

Aim: The prognosis of resectable pancreatic cancer patients with the same stage of disease is highly variable. The purpose of this study is to establi......

Full Text Link